Form 4: Omega Healthcare Investors Director Kevin J. Jacobs Acquires Shares as Part of Compensation

Director Kevin J. Jacobs acquired 7,522 shares of Omega Healthcare Investors, Inc. as part of director compensation.

Summary

• On June 7, 2024, Kevin J. Jacobs, a director of Omega Healthcare Investors, Inc. (OHI), acquired 7,522 shares of common stock.
• The acquisition was part of director compensation, granted via a Restricted Stock Grant Award Agreement.
• The price per share was $32.57.
• These shares will vest approximately one year from the grant date, specifically on the date of the Company's 2025 Annual Meeting of Shareholders, and will convert to common stock on a one-for-one basis.
• Following the transaction, Jacobs directly owns 33,696 shares of OHI.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard director compensation practices and aligns director interests with shareholders.

Positives

• The acquisition reflects Jacobs' continued investment in the company.
• The restricted stock grant aligns Jacobs' interests with those of shareholders, as the shares vest over time.

Future Outlook

The shares will vest on the date of the Company's 2025 Annual Meeting of Shareholders.

Industry Context

Director share acquisitions are common in publicly traded companies as part of compensation packages to align management interests with shareholder value. This is a standard practice in the real estate investment trust (REIT) sector.

Comparison to Industry Standards

• Director compensation packages often include stock grants or options to incentivize long-term performance, which is a common practice among REITs like Welltower (WELL), Ventas (VTR), and Healthpeak Properties (PEAK).
• The vesting schedule of approximately one year is fairly standard for restricted stock grants.
• The size of the grant is within typical ranges for director compensation at companies of similar market capitalization.

Stakeholder Impact

• The acquisition of shares by a director can be viewed positively by shareholders as it demonstrates confidence in the company's future performance.
• The vesting schedule encourages the director to focus on long-term value creation.

Key Dates